Myadec Primetime 50+ Formulation (Cancelled under s.30(2)(ba) and (e))
Product name
Myadec Primetime 50+ Formulation
Sponsor
ARTG
181750
Date action takes effect
Compliance action
Complementary medicine cancellation
Type of action
Cancelled under s.30(2)(ba) and (e)
Grounds for regulatory action
As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect. The goods do not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act.